LASA.NS
Lasa Supergenerics Limited [LASA.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
LASA.NS Stock Summary
Top 10 Correlated Stocks
LASA.NS
In the News
LASA.NS Financial details
Company Rating
-
Market Cap
1.28B
Income
-214.42M
Revenue
1.17B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
89
Optionable
No
Shortable
Yes
Earnings
05 Jun 2024
P/E
-7.14
Forward P/E
-
PEG
-0.22
P/S
1.4
P/B
1.57
P/C
-
P/FCF
-
Quick Ratio
0.1
Current Ratio
0.99
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-4.51
EPS next Y
-
EPS next Q
-
EPS this Y
620.56%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
7.95%
Revenue last 5Y
-5.24%
Revenue Q/Q
9.7%
EPS Q/Q
6204.35%
-
-
-
-
SMA20
-8.56%
SMA50
-30.4%
SMA100
-28.68%
Inst Own
-
Inst Trans
-
ROA
-15%
ROE
-21%
ROC
-0.03%
Gross Margin
28%
Oper. Margin
-3%
Profit Margin
-20%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
20.6-41.2
52W High
-58.32%
52W Low
-14.55%
RSI
37.75
Rel Volume
0.64
Avg Volume
123.12K
Volume
78.69K
Perf Week
-3.72%
Perf Month
-21.68%
Perf Quarter
-39.57%
Perf Half Y
-28.73%
-
-
-
-
Beta
0.515
-
-
Volatility
0.31%, 1.39%
Prev Close
-3.61%
Price
17.09
Change
-4.1%
Company Profile
- Volume Average 123.12K
- Market Capitalization 1.28B
- Employee 89
- CEO Dr. Omkar Pravin Herlekar
- Headquarters Mumbai,IN
- IPO Date 2017-09-21
-
Website
https://lasalabs.com 
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products primarily in India. It offers veterinary and other API products, anthelmintic products, animal feed ingredients, and reagents for therapeutic use. The company also exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Mumbai, India.
